S100鈣結(jié)合蛋白(S100)真核蛋白
Eukaryotic S100 Calcium Binding Protein (S100)
S100-A1; S100A1; S100-Alpha; S-100 Protein; S-100 protein subunit alpha; S-100 protein alpha chain
- 編號EPA012Hu61
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源真核表達(dá)
- 宿主293F cell
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位線粒體, 細(xì)胞質(zhì)
- 預(yù)測分子量11.8kDa
- 實際分子量13kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Met1~Ser94 with N-terminal His Tag
- 緩沖液成份磷酸鹽緩沖液(pH7.4,含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.)
- 性狀凍干粉
- 純度> 95%
- 等電點(diǎn)4.1
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 960 ¥ 2400 ¥ 4800 ¥ 14400 ¥ 36000
- 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
EPA012Hu61 | S100鈣結(jié)合蛋白(S100)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA012Hu01 | S100鈣結(jié)合蛋白(S100)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA012Hu01 | S100鈣結(jié)合蛋白(S100)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA012Hu61 | S100鈣結(jié)合蛋白(S100)活性蛋白 | Cell?culture;?Activity?Assays. |
PAA012Hu02 | S100鈣結(jié)合蛋白(S100)多克隆抗體 | WB; IHC; ICC; IP. |
PAA012Hu01 | S100鈣結(jié)合蛋白(S100)多克隆抗體 | WB; IHC; ICC; IP. |
LAA012Hu71 | S100鈣結(jié)合蛋白(S100)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
LAA012Hu81 | S100鈣結(jié)合蛋白(S100)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
MAA012Hu23 | S100鈣結(jié)合蛋白(S100)單克隆抗體 | WB; IHC; ICC; IP. |
MAA012Hu24 | S100鈣結(jié)合蛋白(S100)單克隆抗體 | WB; IHC; ICC; IP. |
MAA012Hu27 | S100鈣結(jié)合蛋白(S100)單克隆抗體 | WB; IHC; ICC; IP. |
MAA012Hu21 | S100鈣結(jié)合蛋白(S100)單克隆抗體 | WB; IHC; ICC; IP. |
MAA012Hu25 | S100鈣結(jié)合蛋白(S100)單克隆抗體 | WB; IHC; ICC; IP. |
MAA012Hu22 | S100鈣結(jié)合蛋白(S100)單克隆抗體 | WB; IHC; ICC; IP. |
MAA012Hu29 | S100鈣結(jié)合蛋白(S100)單克隆抗體 | WB; IHC; ICC; IP. |
FAA012Hu02 | 抗S100鈣結(jié)合蛋白(S100)單克隆抗體 | FCM |
FAA012Hu04 | 抗S100鈣結(jié)合蛋白(S100)單克隆抗體 | FCM |
FAA012Hu06 | 抗S100鈣結(jié)合蛋白(S100)單克隆抗體 | FCM |
SEA012Hu | S100鈣結(jié)合蛋白(S100)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
AEA012Hu | 抗S100鈣結(jié)合蛋白抗體(Anti-S100)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antibody Detection. |
SCA012Hu | S100鈣結(jié)合蛋白(S100)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
PSA012Hu01 | S100鈣結(jié)合蛋白(S100)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
KSA012Hu01 | S100鈣結(jié)合蛋白(S100)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Brain Research | Vasoactive intestinal peptide protects against ischemic brain damage induced by focal cerebral ischemia in rats [ScienceDirect: S0006899311008663] |
J Exp Neurosci | A New Technique for Collection of Cerebrospinal Fluid in Rat Pups [PubMed: 26056488] |
PLoS One | Regulation of Nutritional Metabolism in Transition Dairy Cows: Energy Homeostasis and Health in Response to Post-Ruminal Choline and Methionine [pubmed:27501393] |
brain research | Ellagic acid exerts protective effect in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease: Possible involvement of ERβ/Nrf2/HO-1 signaling. [pubmed:28238669] |
КиберЛенинка | Levels of neurotropic autoantibodies in patients with schizophrenia [article:n] |
Biomed?Research International | Epigallocatechin-3-Gallate Reduces Neuronal Apoptosis in Rats after Middle Cerebral Artery Occlusion Injury via PI3K/AKT/eNOS Signaling Pathway [Pubmed:29770336] |
Metabolic?Brain?Disease | Trigonelline protects hippocampus against intracerebral Aβ (1–40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms [Pubmed: 30421246] |
ВОЗМОЖНОСТЬ ПРОГНОЗИРОВАНИЯ ОСТРОЙ НЕСПЕЦИФИЧЕСКОЙ БОЛИ В НИЖНЕЙ ЧАСТИ СПИНЫ С ИСПОЛЬЗОВАНИЕМ СЫВОРОТОЧНЫХ?… [] | |
ВЛИЯНИЕ ХРОНИЧЕСКОГО ВВЕДЕНИЯ НЕЙРОЛЕПТИКОВ НА УРОВНИ НЕЙРОСПЕЦИФИЧЕСКИХ АУТОАНТИТЕЛ В КРОВИ У КРЫС [] |
留言咨詢